2024 update in heart failure

A Beghini, AM Sammartino, Z Papp… - ESC Heart …, 2024 - Wiley Online Library
In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

Measurement of Cardiac-Specific Biomarkers in the Emergency Department: New Insight in Risk Evaluation

N Aspromonte, M Zaninotto, A Aimo, I Fumarulo… - International Journal of …, 2023 - mdpi.com
The aim of this article review is to analyze some models and clinical issues related to the
implementation of accelerated diagnostic protocols based on specific cardiac biomarkers in …

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure

T Ha Manh, D Do Anh, T Le Viet - The Egyptian Heart Journal, 2023 - Springer
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for
the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body …

[HTML][HTML] Retrieval Augmented Generation Enabled Generative Pre-Trained Transformer 4 (GPT-4) Performance for Clinical Trial Screening

O Unlu, J Shin, CJ Mailly, MF Oates, MR Tucci… - medRxiv, 2024 - ncbi.nlm.nih.gov
Background: Subject screening is a key aspect of all clinical trials; however, traditionally, it is
a labor-intensive and error-prone task, demanding significant time and resources. With the …

[HTML][HTML] Cardiac Biomarkers in a Brazilian Indigenous Population Exposed to Arboviruses: A Cross-Sectional Study

JM Nicacio, CDF Souza, OV Gomes, BV Souza… - Viruses, 2024 - mdpi.com
Arthropod-borne viral diseases are acute febrile illnesses, sometimes with chronic effects,
that can be debilitating and even fatal worldwide, affecting particularly vulnerable …

Association between natriuretic peptides and C-reactive protein with frailty in heart failure: a systematic review and meta-analysis

K Prokopidis, H Ishiguchi, C Jordan, K Irlik… - Aging Clinical and …, 2024 - Springer
Background Heart failure (HF) and frailty are accompanied by a bidirectional relationship,
sharing common risk factors including elevated levels of natriuretic peptides and …

Clinical Performance of an N-Terminal Pro-B-Type Natriuretic Peptide Assay in Acute Heart Failure Diagnosis

LB Daniels, P Ajongwen… - The journal of …, 2024 - academic.oup.com
Abstract Background We evaluated the Vitros® Immunodiagnostic Products N-terminal pro B-
type natriuretic peptide (NT-proBNP) II assay for aiding in diagnosis of heart failure (HF) in …

[HTML][HTML] Recommendations for the use of natriuretic peptides for early diagnosis of heart disease in patients with diabetes: A consensus report by SPEDM, SPC …

JS Neves, R Baptista, EA de Pape, MR Pereira… - Revista Portuguesa de …, 2024 - Elsevier
Diabetes mellitus is a significant risk factor for the development of heart disease (HD), with
heart failure (HF) being one of the early manifestations of the disease in this population. The …

Patient Adjusted Brain Natriuretic Peptide Assessment Improves Diagnostic Performance

H Gibbs, D Buxton - Beyond Evidence-Based Medicine: Clinical Pearls …, 2023 - Springer
Patient Adjusted Brain Natriuretic Peptide Assessment Improves Diagnostic Performance |
SpringerLink Skip to main content Advertisement SpringerLink Account Menu Find a journal …

Relevant Aspects of Natriuretic Peptides in the Etiology of Dyspnea in the Emergency Room: Evidence, Indications, Confounding Factors, and Cost-Effectiveness

H Villacorta - ABC Heart Fail Cardiomyop, 2024 - abcheartfailure.org
Natriuretic peptides are hormones released by the heart after acute or chronic aggression.
They are produced exclusively by the heart and are, therefore, specific cardiac biomarkers …